您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。 [Dealroom.co]:2024年全球保险技术状况 - 发现报告

2024年全球保险技术状况

金融 2024-11-05 Dealroom.co 「若久」
报告封面

November 2024 Benchmark insurer in the Spanishmarket and largest Spanishmultinational insurance group in theworld European early-stage venture capitalfirm investing in B2B technologycompanies Global startup & venture capitalintelligence platform Dealroom.co is the foremost data provider on startup,early-stage and growth company ecosystems inEurope and around the globe. Founded in 2015, Mundi Ventures is a Venture Capitalfirm headquartered in Madrid with €500 million inassets under management. Mundi Ventures and itsteam have supported over 60 tech companiesworldwide, with a focus on Insurance, Retail, andDeep Tech Technologies. MAPFRE is a global insurance company. It is thebenchmark insurer in the Spanish market, themultinational leader in Latin America and the largestSpanish multinational insurance group in the world.MAPFRE is committed to boosting customer-centereddigital transformation, via MAPFRE Open Innovation,and creating a positive impact on the business andsociety. Founded in Amsterdam in 2013, we now work withmany of the world's most prominent investors,entrepreneurs and government organizations toprovide transparency, analysis and insights onventure capital activity. The Mundi Insurtech Fund has built a truly uniquevalue proposition for Insurtech startups: it is indeed afully independent VC Fund, backed by severalinternational insurers, mutual funds, and familyoffices investors from USA, France, Spain, TheNetherlands Switzerland, Middle East, and SouthAfrica. Mundi is invested in 6 unicorns, includingwefox (Berlin), bolttech (Singapore), Betterfly(Santiago), or SHIFT Technologies (France). Since its inception, more than 4.4 million customershave benefited from solutions originating from thismodel. Click here for more information about theinnovation at MAPFRE Key Takeaways Insurtech funding is stabilizing.Late-stage is the toughest hit, but also atearly and breakout stage the bar is higherfor insurtechs to raise. B2B SaaS is on the rise in insurtech,attracting a record share of funding.AI is fueling this, through AI-native playersor product expansion. GenAI both optimizes insurance processesand poses societal challenges.Climate risk intelligence is gainingimportance as climate losses pile.Healthcare is moving to prevention. 43% of insurtech VC funding has gone to B2B SaaS in 2024,by far the highest share ever. Insurtech funding in 2024 is projected to be almost on parwith last year. Insurtech funding had peaked in 2021 andthen dropped by over two thirds. Now we are back to 2018levels. GenAI intersects insurance in multiple ways. GenAI is startingto optimize insurance processes, but on the other hand,insurers must contribute to societal awareness andeducation by taking preventive measures to reduce the risksto which individuals and companies are exposed. This includes insurance payments providers, underwritingand risk management software, claim management andadministration, as well as admin tech and core insuranceplatforms.Key insurtech function (product and price, underwriting and Late-stage has fallen nearly 90% from its peak in 2021. Earlyand breakout stage are faring better but are still down ~50%from peak. Climate risk intelligence has received considerable andstable funding since 2021. claim) have also attracted the most of the funding in 2024 forthe first time ever as a value chain segment. Challenger insurtech might not disrupt insurance, but theyare alive and might make it in the end. Hippo, Root andLemonadeʼs share prices have recovered since 2023 and theyhave all grown their revenue at a fast pace while improvingefficiency. With chronic diseases accounting for 70-90+% of healthcareexpenses in developed markets, preventive care, earlyintervention, and better management are gaining increasedimportance. Many of these startups are also AI-native or expanding theirproduct suite with additional AI products. AI is still both anopportunity and a threat for these players. Global VC funding in insurtech startups ▊$0–1m (pre-seed)▊$1–4m (seed)▊$4–15m (series A)▊$15–40m(series B)▊$40–100m (series C)▊$100–250m (mega rounds)▊$250m+ (mega+)▊Projection Table of Contents 1.The status of global insurtech2.Deep dive topics: Generative AI, Climate risk intelligence,Health prevention 1.The status of global insurtech Insurtech VCfunding in 2024is projected to bealmost on parwith last year. Looking back, itpeaked in 2021and thendropped overtwo thirds.Now we are backto 2018 levels. Insurtech VCfunding in 2024is laggingslightly behindlast year, thoughpositive trendssuggest a pick-upin Q4. With $3.2B raised in 2024, insurtech shows strong investor confidence, despite a 7% dipfrom last year, slightly underperforming the market but still outpacing fintech. “After the uncertainty of previous years, the globalinsurtech market is now showing signs of furtherstabilization. While the frenzy has cooled, weʼre seeing apositive rebound in the early-growth / breakout stages,particularly wit